Industry: Food & Beverages
Published Date: 2025-03-03
Pages: 168 Pages
Report ld: 4404245
Request Sample
Customized Report
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
North American market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Aflatoxin M1 Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Aflatoxin M1 Immunoaffinity Columns (IAC), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aflatoxin M1 Immunoaffinity Columns (IAC) by region & country, by Type, and by Application.
The Aflatoxin M1 Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aflatoxin M1 Immunoaffinity Columns (IAC).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aflatoxin M1 Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aflatoxin M1 Immunoaffinity Columns (IAC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aflatoxin M1 Immunoaffinity Columns (IAC) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Product Introduction
1.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size Forecast
1.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2020-2031)
1.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (2020-2031)
1.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Price (2020-2031)
1.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Trends & Drivers
1.3.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Industry Trends
1.3.2 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Drivers & Opportunity
1.3.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Challenges
1.3.4 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Players Revenue Ranking (2024)
2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Company (2020-2025)
2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2024)
2.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Company Players (2020-2025)
2.5 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Company (2020-2025)
2.6 Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturing Base and Headquarters
2.7 Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Aflatoxin M1 Immunoaffinity Columns (IAC)
2.9 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Competitive Analysis
2.9.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflatoxin M1 Immunoaffinity Columns (IAC) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 80% Below
3.1.2 80-90%
3.1.3 91-100%
3.1.4 100% Above
3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type
3.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Type (2020-2031)
3.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Type (%) (2020-2031)
3.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type
3.3.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Type (2020-2031)
3.3.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Type (%) (2020-2031)
3.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Milk
4.1.2 Goat Milk
4.1.3 Soy Milk
4.1.4 Others
4.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application
4.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Application (2020-2031)
4.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Application (%) (2020-2031)
4.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application
4.3.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Application (2020-2031)
4.3.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Application (%) (2020-2031)
4.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region
5.1.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2020-2025)
5.1.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2026-2031)
5.1.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (%), (2020-2031)
5.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region
5.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2020-2025)
5.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2026-2031)
5.2.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (%), (2020-2031)
5.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
5.4.2 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
5.5.2 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
5.6.2 Asia Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
5.7.2 South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
5.8.2 Middle East & Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value
6.2.1 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.3.2 United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.4.2 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.5.2 China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.6.2 Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.7.2 South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.8.2 Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2020-2031
6.9.2 India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Company Information
7.1.2 Gold Standard Diagnostics Horsham Introduction and Business Overview
7.1.3 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.1.5 Gold Standard Diagnostics Horsham Recent Development
7.2 LCTech
7.2.1 LCTech Company Information
7.2.2 LCTech Introduction and Business Overview
7.2.3 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.2.5 LCTech Recent Development
7.3 Shimadzu
7.3.1 Shimadzu Company Information
7.3.2 Shimadzu Introduction and Business Overview
7.3.3 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.3.5 Shimadzu Recent Development
7.4 Biotez Berlin
7.4.1 Biotez Berlin Company Information
7.4.2 Biotez Berlin Introduction and Business Overview
7.4.3 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.4.5 Biotez Berlin Recent Development
7.5 PerkinElmer
7.5.1 PerkinElmer Company Information
7.5.2 PerkinElmer Introduction and Business Overview
7.5.3 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.5.5 PerkinElmer Recent Development
7.6 VICAM
7.6.1 VICAM Company Information
7.6.2 VICAM Introduction and Business Overview
7.6.3 VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.6.5 VICAM Recent Development
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Company Information
7.7.2 Ring Biotechnology Introduction and Business Overview
7.7.3 Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.7.5 Ring Biotechnology Recent Development
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Company Information
7.8.2 R-Biopharm AG Introduction and Business Overview
7.8.3 R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.8.5 R-Biopharm AG Recent Development
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Company Information
7.9.2 CHROMATIFIC Introduction and Business Overview
7.9.3 CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.9.5 CHROMATIFIC Recent Development
7.10 Neogen
7.10.1 Neogen Company Information
7.10.2 Neogen Introduction and Business Overview
7.10.3 Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.10.5 Neogen Recent Development
7.11 Kwinbon Biotechnology
7.11.1 Kwinbon Biotechnology Company Information
7.11.2 Kwinbon Biotechnology Introduction and Business Overview
7.11.3 Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.11.5 Kwinbon Biotechnology Recent Development
7.12 Shandong Meizheng Bio-Tech
7.12.1 Shandong Meizheng Bio-Tech Company Information
7.12.2 Shandong Meizheng Bio-Tech Introduction and Business Overview
7.12.3 Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.12.5 Shandong Meizheng Bio-Tech Recent Development
7.13 Jiangsu Wisdom Engineering & Technology
7.13.1 Jiangsu Wisdom Engineering & Technology Company Information
7.13.2 Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
7.13.3 Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.13.5 Jiangsu Wisdom Engineering & Technology Recent Development
7.14 BIOCOMMA
7.14.1 BIOCOMMA Company Information
7.14.2 BIOCOMMA Introduction and Business Overview
7.14.3 BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.14.5 BIOCOMMA Recent Development
7.15 Beijing Nano-Ace Technology
7.15.1 Beijing Nano-Ace Technology Company Information
7.15.2 Beijing Nano-Ace Technology Introduction and Business Overview
7.15.3 Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.15.5 Beijing Nano-Ace Technology Recent Development
7.16 Femdetection
7.16.1 Femdetection Company Information
7.16.2 Femdetection Introduction and Business Overview
7.16.3 Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.16.5 Femdetection Recent Development
7.17 Wuhan Huamei Wisherkon Biotech
7.17.1 Wuhan Huamei Wisherkon Biotech Company Information
7.17.2 Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
7.17.3 Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.17.5 Wuhan Huamei Wisherkon Biotech Recent Development
7.18 Changsha Huaxue Biological Technology
7.18.1 Changsha Huaxue Biological Technology Company Information
7.18.2 Changsha Huaxue Biological Technology Introduction and Business Overview
7.18.3 Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.18.5 Changsha Huaxue Biological Technology Recent Development
7.19 Anavo
7.19.1 Anavo Company Information
7.19.2 Anavo Introduction and Business Overview
7.19.3 Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.19.5 Anavo Recent Development
7.20 Shandong Vnya Bio-technology
7.20.1 Shandong Vnya Bio-technology Company Information
7.20.2 Shandong Vnya Bio-technology Introduction and Business Overview
7.20.3 Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.20.5 Shandong Vnya Bio-technology Recent Development
7.21 Guanyibio
7.21.1 Guanyibio Company Information
7.21.2 Guanyibio Introduction and Business Overview
7.21.3 Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.21.5 Guanyibio Recent Development
7.22 Prufunglab
7.22.1 Prufunglab Company Information
7.22.2 Prufunglab Introduction and Business Overview
7.22.3 Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.22.5 Prufunglab Recent Development
8 Industry Chain Analysis
8.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Industrial Chain
8.2 Aflatoxin M1 Immunoaffinity Columns (IAC) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Model
8.5.2 Sales Channel
8.5.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 159
USD 3950.00
(Single User License)
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 145
USD 2900.00
(Single User License)
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 181
USD 4900.00
(Single User License)
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-03
Pages: 109
USD 2900.00
(Single User License)
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published Date: 2024-04-25
Pages: 128
USD 4900.00
(Single User License)
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published Date: 2024-02-22
Pages: 162
USD 3950.00
(Single User License)
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 159
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 145
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 181
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-03
Pages: 109
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published: 2024-04-25
Pages: 128
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published: 2024-02-22
Pages: 162
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now